NCT07594821

Brief Summary

Carpal tunnel syndrome (CTS) is a condition that can cause pain, numbness, or tingling in the hand and wrist. The most common surgery for CTS is called carpal tunnel release, which aims to relieve pressure on the main nerve in the wrist. However, after this surgery, some patients (up to 4 out of 10) still have symptoms, and about 1 in 8 may need another surgery. One reason symptoms can continue is that the nerve may also be compressed higher up in the arm, near a ligament called the Lacertus fibrosus. Releasing this area might help, but it is often not checked or treated during the first surgery because current tests (like physical exams, nerve studies, and ultrasounds) cannot reliably detect it. This study is comparing two approaches for people with CTS:

  1. 1.Standard surgery - only releasing the carpal tunnel.
  2. 2.Extended surgery - releasing both the carpal tunnel and the Lacertus fibrosus.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started May 2026

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Feb 2028

Study Start

First participant enrolled

May 6, 2026

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 19, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

1.7 years

First QC Date

May 11, 2026

Last Update Submit

May 11, 2026

Conditions

Keywords

carpal tunnel syndromeproximal median nerve compressionlacertus syndromedouble crushnerve decompressioncarpal tunnel releaselacertus release.

Outcome Measures

Primary Outcomes (1)

  • Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ SSS)

    At twelve months follow-up

Secondary Outcomes (12)

  • BCTQ FSS

    From enrollment until 12 months of follow-up

  • Anchor questions

    At 12 months follow-up

  • Residual, persistent en recurrent CTS symptoms

    From 6 weeks after surgery until 12 months of follow-up

  • Pillar pain

    From 6 weeks after surgery until 12 months of follow-up

  • Secondary surgery

    From 6 weeks until 12 months of follow-up.

  • +7 more secondary outcomes

Other Outcomes (1)

  • Patient Demographics

    At baseline

Study Arms (2)

carpal tunnel release

OTHER

Control group

Procedure: Carpal tunnel release

carpal tunnel release combined with Lacertus release

OTHER

Intervention group

Procedure: Combined carpal tunnel and lacertus release

Interventions

Carpal tunnel release is a surgical procedure to treat carpal tunnel syndrome by cutting the ligament (transverse carpal ligament) covering the wrist's carpal tunnel. This action relieves pressure on the median nerve, alleviating pain, numbness, and weakness in the hand. It is usually an outpatient procedure done under local anesthesia.

carpal tunnel release

A transverse incision is made on the forearm's volar (anterior) aspect, approximately 3cm distal of the elbow crease. This incision is placed over the palpable brachioradialis and biceps tendon. The subcutaneous tissue is dissected to expose the fascia overlying the flexor pronator muscles. The brachial fascia is identified and incised to reveal the underlying Lacertus fibrosus (also known as the bicipital aponeurosis). The Lacertus fibrosus is a tendinous band extending from the biceps tendon medially across the forearm. Care is taken to avoid injury to the underlying structures, particularly the median nerve, which lies deep and slightly medial to the Lacertus fibrosus. The Lacertus fibrosus is incised transversely. The surgeon ensures that the median nerve is fully decompressed and that there are no remaining constrictive bands. It is usually an outpatient procedure done under local anesthesia.

carpal tunnel release combined with Lacertus release

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients being at least 18 years or older
  • CTS confirmed by EMG or nerve ultrasound
  • Patient opts for surgical treatment

You may not qualify if:

  • Previous surgical decompression of the median nerve at the ipsilateral wrist or forearm
  • Severe thenar atrophy: Examination of the thenar is based on clinical observation. The presence of thenar muscle atrophy is scored as none, mild, or severe.
  • Simultaneous nerve decompression in the ipsilateral arm (e.g. cubital tunnel, Guyon and radial nerve release.
  • Neurological disorders affecting peripheral nerves (e.g. spinal cord compression or injury, muscular dystrophy, dystonia, ALS)
  • Malunion of the distal radius
  • Impaired hand function
  • Pregnancy
  • Inability to complete study forms due to insufficient comprehension of the Dutch language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Maasstad Ziekenhuis

Rotterdam, South Holland, 3079 DZ, Netherlands

RECRUITING

Spijkenise Medisch Centrum

Rotterdam, South Holland, 3201 GZ, Netherlands

RECRUITING

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Central Study Contacts

Sebastian Poggio Voormolen, BSc, PhD candidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2026

First Posted

May 19, 2026

Study Start

May 6, 2026

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Last Updated

May 19, 2026

Record last verified: 2026-05

Locations